About Multimeric Biotherapeutics
►"Multimeric" makes medicines that unleash the power of the immune system to treat cancer and serious infections.
► The lead compound is MegaCD40L™, a unique 2-trimer form of CD40 ligand (CD40L), where CD40L is the most powerful immune stimulator made by the body.
► Multimeric's technology is protected by issued patents worldwide.
► The initial clinical program is an immunotherapy for ovarian cancer.
► A second clinical program is a "therapeutic vaccine” for chronic Hepatitis B Virus (HBV) infection, a life-threatening problem for 240 million people worldwide.
► Follow-on clinical programs will use MegaCD40L™ for cancer immunotherapy and vaccines for infectious diseases.
► Separately, Multimeric earns revenues from sales of its unique lab reagents.
Meet us at JP Morgan Healthcare Conference and Biotech Showcase, Jan. 13-16, 2014, San Francisco, CA